COFFMAN ROBERT 4/A
4/A · DYNAVAX TECHNOLOGIES CORP · Filed Mar 22, 2018
Insider Transaction Report
Form 4/AAmended
COFFMAN ROBERT
Chief Scientific Officer & VP
Transactions
- Award
Stock Option (Right to Buy)
2018-02-01+100,000→ 100,000 totalExercise: $16.45Exp: 2025-01-31→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]Twenty percent (20%) of the shares subject to the option will vest upon achievement of certain performance goals, remaining eighty percent (80%) of the shares subject to the option will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date, and one thirty-sixth (1/36) of the shares subject to the option vesting on the last day of each month thereafter. The original Form 4 filed on February 5, 2018 is amended by this Form 4 amendment to correctly reflect the vesting schedule of the shares subject to the option. No other changes have been made to the original form 4.